Medeligo 17+

LiveMed Media Ltd.

    • Gratis
    • In-App-Käufe möglich

iPhone-Screenshots

Beschreibung

Medeligo® provides instant access to the latest oncology literature and information for treatment, procedure, testing, and management information across all oncology subspecialties.

FINGERTIP ACCESS TO THE LATEST ONCOLOGY INFORMATION

- AI-powered search engineered by technologists and medical librarians
- Effortless UI gets to answers in seconds
- Covers more than 2,000 solid tumors and cancers, including the WHO Classification of Tumours
- Real-time searches provide the latest information available
- Searches only the most trusted medical journals, databases, and information resources
- Primary source material: unfiltered, unbiased, uncurated

Benefits include:

- Find and read the latest oncology literature in seconds
- Watch relevant videos and browse images
- Prepare for patient rounds, consults, and surgeries
- Answer patient-specific questions quickly at tumor boards
- Share, print, or save articles

Limited introductory price of $49.99 (Reg. $149.99) for the All Access (1 year) subscription — includes a risk-free 3-month trial.

To learn more, please visit www.medeligo.com.

After the free trial period, your subscription will continue for $49.99/year, and your iTunes account will be charged. If you do not wish to continue your subscription after your free trial ends, turn off auto-renew in your Account Settings 24 hours before the end of your free trial.
Subscriptions will automatically renew when they expire unless you turn off auto-renew at least 24 hours before the end of your subscription period. Your account will be charged $49.99 for renewal within 24 hours before the end of your subscription period. You can manage your subscription and turn off auto-renew by going to your Account Settings.
Any unused portion of a free trial period, if offered, will be forfeited when the user purchases a subscription to that publication, where applicable.

You can read more about our terms and conditions here:
Privacy policy: http://medeligo.com/privacy-policy/
Terms of service: http://medeligo.com/terms-of-service/

Neuheiten

Version 1.5.4

• Users can now delete their accounts.

App-Datenschutz

Der Entwickler, LiveMed Media Ltd., hat darauf hingewiesen, dass die Datenschutzrichtlinien der App den unten stehenden Umgang mit Daten einschließen können. Weitere Informationen findest du in den Datenschutzrichtlinien des Entwicklers.

Mit dir verknüpfte Daten

Die folgenden Daten werden möglicherweise erfasst und mit deiner Identität verknüpft:

  • Kontakt­informa­tionen
  • Kennungen
  • Nutzungs­daten

Nicht mit dir verknüpfte Daten

Die folgenden Daten werden zwar möglicherweise erfasst, aber nicht mit deiner Identität verknüpft:

  • Diagnose

Die Datenschutzpraktiken können zum Beispiel je nach den von dir verwendeten Funktionen oder deinem Alter variieren. Weitere Infos

Das gefällt dir vielleicht auch

Washington Manual of Oncology
Medizin
Bladder Cancer Manager
Medizin
Breast Cancer [BC]
Medizin
ALTAI Oncology
Medizin
DeepThink PTB
Medizin
Ehrinc User
Medizin